Articles

  • Leading Causes: Interrogating the “Why” Behind Health Inequity in Cancer Care

    Leading Causes: Interrogating the “Why” Behind Health Inequity in Cancer Care

    How do social determinants of health impact outcomes in cancer care? New Century Health Associate CMO Dr. Monica Soni and Radiation Oncologist Dr. Onyinye Balogun discuss.

    Watch Video
  • ×

    First Name
    Last Name
    Company Name
    Thank you!
    Error - something went wrong!
  • Bridging the Gaps in Advance Care Planning in Oncology

    Bridging the Gaps in Advance Care Planning in Oncology

    New Century Health and our Vital Decisions solution seek to ensure more cancer patients receive end-of-life care that aligns with their wishes.

    Read Article
  • New Century Health Partner Cancer Care Specialists of Illinois Earns $3.6 Million from Medicare through Federal Oncology Care Model

    New Century Health Partner Cancer Care Specialists of Illinois Earns $3.6 Million from Medicare through Federal Oncology Care Model

    NCH’s high-value clinical oncology pathways, patient triage programs and provider engagement strategies help community practice to succeed in value-based payment program.

    Read Press Release
  • Still Bracing for the Surge in Advanced Cancer Cases

    Still Bracing for the Surge in Advanced Cancer Cases

    The predicted wave of late-stage cancers is taking longer to materialize than we expected.

    Read Article
  • Cancer Moonshot 2.0: Three Big Questions to Track

    Cancer Moonshot 2.0: Three Big Questions to Track

    Which components of the recently announced Cancer Moonshot should get high priority for the initiative to succeed? Our chief medical officer, Dr. Andrew Hertler, outlines three key questions to track.

    Read Article
  • Developing a playbook to tackle health inequities in cancer care

    Developing a playbook to tackle health inequities in cancer care

    New Century Health Associate Chief Medical Officer Monica Soni explores health inequities in cancer cares and shares strategies for how to address them.

    Watch Video
  • Accelerated Drug Approvals Present a Mounting Challenge to Oncologists

    Accelerated Drug Approvals Present a Mounting Challenge to Oncologists

    Dr. Andrew Hertler explains three key criteria for evaluating fast-tracked drugs.

    Read External Article
  • A Plea for Better Endings

    A Plea for Better Endings

    Confronting the heart-wrenching, avoidable circumstances that happen in hospitals and homes every day.

    Watch Video
  • Patient Impact Story: Clinical Review Catches Potential Medical Error

    Patient Impact Story: Clinical Review Catches Potential Medical Error

    Red flags cause clinical reviewers to question a radiation oncologist’s diagnosis.

    Read Article
  • Panel Discussion: Oncology Care Reimagined

    Panel Discussion: Oncology Care Reimagined

    Health plan clinical leaders joined us for an insightful discussion on the path toward high-value cancer care.

    Watch Video
  • Location, Location, Location. That Also Applies to Cancer Treatment.

    Location, Location, Location. That Also Applies to Cancer Treatment.

    Home-based chemotherapy infusions may offer convenience but also raise a host of questions.

    Read External Article
  • Shouldering the Burden and Financial Toxicity of Part D Cancer Drugs

    Shouldering the Burden and Financial Toxicity of Part D Cancer Drugs

    Discussing drug costs should be a core tenet of shared decision-making.

    Read Article
  • New Century Health Parent Company Elects Dr. Tunde Sotunde To Board Of Directors

    New Century Health Parent Company Elects Dr. Tunde Sotunde To Board Of Directors

    Sotunde is president and CEO of Blue Cross and Blue Shield of North Carolina.

    Read Press Release
  • New Century Health to Support Health New England With Comprehensive Advance Care Planning Services

    New Century Health to Support Health New England With Comprehensive Advance Care Planning Services

    Partnership will empower members with serious illness to articulate and advocate for the care they want.

    Read Press Release
  • Specialty Therapies Offering Incremental Benefit Shouldn’t Be Added to Clinical Pathways, Hertler Says

    Specialty Therapies Offering Incremental Benefit Shouldn’t Be Added to Clinical Pathways, Hertler Says

    Evidence-Based Oncology interviews our CMO about mismatches between drug costs and efficacy.

    Read External Article
  • The Mainstreaming of Targeted Lung Cancer Treatment

    The Mainstreaming of Targeted Lung Cancer Treatment

    Our CMO speaks with Managed Care Executive about the promise and perils of genomic testing.

    Read External Article
  • Health Systems' Rare Rejection of Alzheimer's Drug Sparks Questions About FDA Approvals

    Health Systems' Rare Rejection of Alzheimer's Drug Sparks Questions About FDA Approvals

    Modern Healthcare spoke with NCH's Dr. Andrew Hertler about problems in the FDA's approval process.

    Read Article
  • Specialty Pharmacies Grapple with Assessing Costs and Value of Oncology Therapies

    Specialty Pharmacies Grapple with Assessing Costs and Value of Oncology Therapies

    Our CMO speaks with Formulary Watch about the challenges of high--cost drugs with marginal benefit.

    Read Article
  • Evolent Health, Parent Company of New Century Health, Announces Agreement to Acquire Vital Decisions

    Evolent Health, Parent Company of New Century Health, Announces Agreement to Acquire Vital Decisions

    The addition of Vital Decisions’ specialized patient engagement services expected to position New Century Health to accelerate growth, improve patient care quality and increase margins.

    Read Article
  • Hitting the Brakes on Fast-Tracked Drugs

    Hitting the Brakes on Fast-Tracked Drugs

    The FDA's Aduhelm approval was highly controversial, but not as surprising for those who follow the oncology drug pipeline.

    Read Article
  • loading
    Loading More...